Physician profile
Ryan Peterson
NPI 1245486307
$5,136.67
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.19 · 2020: $75.40 · 2021: $941 · 2022: $3,916 · 2023: $14.26 · 2024: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $134.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $4,101.95 | 2019-2024 | Restrata Wound Matrix |
| Anika Therapeutics, INC. | $556.56 | 2021-2022 | |
| Abbott Laboratories | $109.73 | 2021 | |
| Abbvie INC. | $67.40 | 2021-2023 | |
| Organogenesis INC. | $41.87 | 2020-2022 | |
| In2bones USA, LLC | $37.00 | 2021 | |
| Averitas Pharma INC. | $34.86 | 2024 | Qutenza |
| Kci USA, INC. | $27.49 | 2020 | |
| Mimedx Group, INC. | $26.84 | 2024 | |
| Smith+Nephew, INC. | $25.37 | 2020-2021 | |
| Tactile Systems Technology INC | $22.73 | 2019-2020 | |
| Boston Scientific Corporation | $16.99 | 2024 | |
| Bioventus LLC | $15.37 | 2022 | |
| Stryker Corporation | $14.03 | 2024 | Dart-Fire |
| Nevro Corp. | $13.96 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $12.66 | 2019 | |
| Arthrosurface Incorporated | $11.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.